Event Rates and Risk Factors for Recurrent Cardiovascular Events and Mortality in a Contemporary Post Acute Coronary Syndrome Population Representing 239 234 Patients During 2005 to 2018 in the United States
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Event Rates and Risk Factors for Recurrent Cardiovascular Events and Mortality in a Contemporary Post Acute Coronary Syndrome Population Representing 239 234 Patients During 2005 to 2018 in the United States
Authors
Keywords
-
Journal
Journal of the American Heart Association
Volume 11, Issue 9, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2022-04-27
DOI
10.1161/jaha.121.022198
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparability of Event Adjudication Versus Administrative Billing Claims for Outcome Ascertainment in the DAPT Study
- (2021) Kamil F. Faridi et al. Circulation-Cardiovascular Quality and Outcomes
- Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
- (2021) Kazem Rahimi et al. LANCET
- Novel Lipid-Lowering Therapies to Reduce Cardiovascular Risk
- (2021) John T. Wilkins et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
- (2021) Jennifer S. Lawton et al. CIRCULATION
- Age-Stratified Sex Disparities in Care and Outcomes in Patients with ST-elevation Myocardial Infarction
- (2020) Jing Liu et al. AMERICAN JOURNAL OF MEDICINE
- Time‐Dependent Cardiovascular Treatment Benefit Model for Lipid‐Lowering Therapies
- (2020) Irfan Khan et al. Journal of the American Heart Association
- 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
- (2020) Jean-Philippe Collet et al. EUROPEAN HEART JOURNAL
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
- (2019) Scott M. Grundy et al. CIRCULATION
- Evaluation of Mortality Data From the Social Security Administration Death Master File for Clinical Research
- (2019) Ann Marie Navar et al. JAMA Cardiology
- Sex Differences Persist in Time to Presentation, Revascularization, and Mortality in Myocardial Infarction Treated With Percutaneous Coronary Intervention
- (2019) Julia Stehli et al. Journal of the American Heart Association
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Biomarkers and Clinical Cardiovascular Outcomes With Ezetimibe in the IMPROVE-IT Trial
- (2019) Arman Qamar et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes
- (2019) Stefanie Schüpke et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sex-Based Differences in Presentation, Treatment, and Complications Among Older Adults Hospitalized for Acute Myocardial Infarction
- (2019) Michael G. Nanna et al.
- Not All Insurance Is Equal: Differential Treatment and Health Outcomes by Insurance Coverage Among Nonelderly Adult Patients With Heart Attack
- (2018) Matthew J. Niedzwiecki et al. Journal of the American Heart Association
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
- (2018) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
- (2017) Borja Ibanez et al. EUROPEAN HEART JOURNAL
- Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention
- (2017) Erin A. Bohula et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Simulation of Lipid-Lowering Therapy Intensification in a Population With Atherosclerotic Cardiovascular Disease
- (2017) Christopher P. Cannon et al. JAMA Cardiology
- Introduction to the Analysis of Survival Data in the Presence of Competing Risks
- (2016) Peter C. Austin et al. CIRCULATION
- Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial InfarctionClinical Perspective
- (2016) Erin A. Bohula et al. CIRCULATION
- Real-World Evidence — What Is It and What Can It Tell Us?
- (2016) Rachel E. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Agreement between Medicare pharmacy claims, self-report, and medication inventory for assessing lipid-lowering medication use
- (2016) Lisandro D. Colantonio et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Study of Cardiovascular Health Outcomes in the Era of Claims DataCLINICAL PERSPECTIVE
- (2015) Bruce M. Psaty et al. CIRCULATION
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
- (2015) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
- (2014) Ezra A. Amsterdam et al. CIRCULATION
- Validity of Claims-Based Stroke Algorithms in Contemporary Medicare Data: Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study Linked With Medicare Claims
- (2014) H. Kumamaru et al.
- Validity of Myocardial Infarction Diagnoses in Administrative Databases: A Systematic Review
- (2014) Natalie McCormick et al. PLoS One
- 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary
- (2012) Patrick T. O’Gara et al. CIRCULATION
- A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data
- (2012) Susan E. Andrade et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
- (2011) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
- (2011) Pierluigi Tricoci et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Outcome of a Routine Versus Selective Invasive Strategy in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome
- (2010) Keith A.A. Fox et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured population
- (2010) Peter M. Wahl et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started